PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “zinc”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 325 records · Page 18Linked to original sources

Active zinc binding sites of zinc metalloenzymes.

The participation of zinc in widely diversified biological reactions focuses attention on its chemistry. A number of its properties relate to its biological utilization and versatility. Its amphoteric properties allow the zinc-coordinated water to exist as a "hydronium" or hydroxide ion even at neutrality. Its coordination sphere is flexible and adapts to a wide variety of ligands, allowing for a multiplicity of types and numbers of coordination complex geometries. Its stable d shell signifies that it is neither oxidized nor reduced; yet it participates in enzymatic oxidoreduction reactions in coordination with an organic cofactor. X-ray crystallographic analyses of twelve zinc enzymes now show that catalytic zinc is bound by three protein ligands, whereas structural zinc atoms are fully coordinated by four ligands. Water is always a ligand to the catalytic zinc while the protein ligands occur in an order of frequency of His >> Glu > Asp = Cys. The zinc-bound water is the critical component of the active site; it is activated for enzymatic catalysis by the identity and arrangement of the ligands coordinated to zinc. Thus, ultimately, it is this water molecule which, upon entering the zinc coordination sphere, is activated either by ionization, polarization or displacement. As a result of the properties of this metal, zinc metalloenzymes and zinc proteins participate in a wide variety of metabolic processes including carbohydrate, lipid, protein and nucleic acid synthesis, regulation and degradation.

Amino Acid Sequence↗

Zinc deficiency and the kidney. II. Response of zinc-deficient rats to three diuretic drugs.

Carbonic anhydrase is a zinc metalloenzyme whose activity may be affected by zinc deficiency. This investigation was designed to evaluate the effect of zinc deficiency on the response to three diuretic drugs which vary in their capacity to inhibit carbonic anhydrase: acetazolamide, furosemide and hydrochlorothiazide. The response of the zinc-deficient rats was compared to that of pair-fed and ad libitum zinc-supplemented controls. The pattern of electrolyte excretion by zinc-deficient rats in response to the three diuretics was qualitatively similar to that of the pair-fed and zinc-supplemented rats. When corrected for differences in body weight between the three groups, the natriuretic response to the diuretics in zinc-deficient rats was greater than that of either the pair-fed or zinc-supplemented controls. Although administration of the diuretics increased potassium excretion in all groups, the response of the zinc-deficient rats was attenuated. These differences in the response of zinc-deficient rats to diuretics did not appear to be related to the capacity of these drugs to inhibit carbonic anhydrase.

Acetazolamide↗

Relative zinc-binding capacity of metallothionein in hepatic cytosols of zinc-injected rats.

In order to determine the zinc-binding capacity of metallothionein in hepatic cytosols of zinc-injected rats, we examined the relationship between zinc contents in cytosols and metallothionein fraction in rat livers. Each rat was injected intraperitoneally once with 0.9% NaCl or zinc (10, 20, 40 or 60 mg zinc/kg b.w.) and was killed 14 h after injection. The distribution profiles of the hepatic cytosols of zinc-injected rats on a Sephadex G-75 column showed that the increased zinc was attributable to the metallothionein and high molecular weight proteins. Our results demonstrated that 63% of the increased zinc in hepatic cytosols of zinc-injected rats was bound to metallothionein and that 23% of the increased zinc was bound to high molecular weight proteins. These results suggest that the mechanisms of zinc accumulation in rat liver are different from those of cadmium accumulation.

Animals↗

Metallokinetic study of zinc in the blood of normal rats given insulinomimetic zinc(II) complexes and improvement of diabetes mellitus in type 2 diabetic GK rats by their oral administration.

In order to understand the insulinomimetic activity of zinc(II) complexes, we studied the metallokinetic features of zinc in the blood of normal rats given the zinc complexes, bis(maltolato)zinc(II) (Zn(mal)(2)) and bis(6-methylpicolinato)zinc(II) (Zn(6mpa)(2)) by comparing each of them with an ionic form of zinc chloride (ZnCl(2)). The bioavailability of the zinc(II) complexes following oral administration was enhanced to 1.4-1.5-fold that of ZnCl(2) with respect to zinc level. Based on the results of a metallokinetic analysis and administration method in normal rats, we examined the antidiabetic ability of the zinc(II) complexes in GK rats, a model animal of type 2 diabetes mellitus. High blood glucose levels of GK rats were normalized following intraperitoneal injections and oral administration of the zinc(II) complexes, in which the Zn(6mpa)(2) complex was found to be more effective than Zn(mal)(2). The present results are noteworthy, not only due to their potential relevance for clinical application, but also for the development of new zinc(II) complexes.

Journal Article↗

Zinc levels after intravenous administration of zinc sulphate in insulin-dependent diabetes mellitus patients.

Diabetic patients commonly have increased urinary excretion of zinc, although blood concentrations may be normal, lowered, or raised. We analyzed zinc levels in plasma and urine after an intravenous overload of zinc sulphate (8 mg) in 22 patients with insulin-dependent diabetes mellitus (IDDM) and 22 healthy individuals. No significant differences were found in basal levels of serum zinc in either group (111 +/- 29 micrograms/dl in IDDM vs 119 +/- 19 micrograms/dl in controls), although urinary excretion of zinc was significantly raised in diabetics (1396 +/- 622 micrograms/24 h) versus controls (611 +/- 235 micrograms/24 h). After zinc overload, both serum and urinary levels of this element varied between the two groups. Serum zinc in IDDM patients initially increased more markedly, and subsequently showed a more significant decline, than in controls. Urinary zinc levels in IDDM patients, in contrast to control values, showed no increase after overload. These alterations in serum and urinary zinc concentrations suggest that our diabetic patients may be zinc-deficient.

Adult↗

Effects of oral zinc loading on zinc metabolism in humans II: in vivo kinetics.

The effects of oral zinc loading on zinc metabolism were studied in 10 patients with taste and smell dysfunction following oral administration of Zn-65 (physical t1/2 = 245 d) and subsequent administration of oral stable zinc. Patients took an ad libitum dietary zinc intake of 8-13 mg daily for 290-440 days (mean, 336) following Zn-65 administration, followed by an intake of an additional 100 mg/day of zinc ion (as ZnSO4) over the next 112-440 days (mean, 307). A previously developed compartmental model, based on five day studies of patients with taste and smell dysfunction, was extended in such a way that it was consistent with both short term and long term kinetics. In this extended model, the turnover of 90% of total body zinc, previously unaccounted for by the kinetics in the short term studies could be explained by a single compartment, as postulated in the short term studies. Using the model, it was found that changes in the rate constants for gastrointestinal absorption and renal excretion of zinc were both necessary and sufficient to explain the changes seen in the kinetic curves following oral zinc loading. Michaelis-Menten type saturation mechanisms were adequate to explain the observed parameter changes. These changes also accounted for the observed mean plasma zinc mass increase of only 37% above pre-load levels in face of an 11-fold increase in zinc intake.

Administration, Oral↗

Sulfidation of zinc plating sludge with Na2S for zinc resource recovery.

A high amount of zinc disposed in the landfill sites as a mixed-metal plating sludge represents a valuable zinc source. To recover zinc from the plating sludge, a sulfidation treatment is proposed in this study, while it is assumed that ZnS formed could be separated by flotation. The sulfidation treatment was conducted by contacting simulated zinc plating sludge with Na(2)S solution at S(2-) to Zn(2+) molar ratio of 1.5 for a period of 1-48 h, while changing the solid to liquid (S:L) ratio from 0.25:50 to 1.00:50. The conversion of zinc compounds to ZnS was determined based on the consumption of sulfide ions. The reaction products formed by the sulfidation of zinc were identified by X-ray diffraction (XRD). As a result, it was found that the conversion of zinc compounds to ZnS increased with an increase in S:L ratio. A maximum conversion of 0.809 was obtained at an S:L ratio of 1.00:50 after 48 h. However, when the zinc sludge treated at S:L ratio of 1.00:50 for 48 h was subjected to XRD analyses, only ZnS was identified in the treated zinc sludge. The result suggested that the rest of zinc sludge remained unreacted inside the agglomerates of ZnS. The formation behavior of ZnS was predicted by Elovich equation, which was found to describe the system satisfactorily indicating the heterogeneous nature of the sludge.

Electroplating↗

Spectroscopic study on the zinc-contaminated soils for the determination of zinc speciation.

The purpose of this paper reported the zinc species in the highly contaminated soils from metallurgical area around Erh-Jen River in the southern of Taiwan. FTIR and XPS were used to investigate the zinc species in the contaminated soils. Through a FTIR analysis, appreciable of zinc bound by organic matter was found and their bonding structure consisted of antisymmetric and symmetric stretchings, Zn-HSsym and Zn-HSasym. With XPS analysis, the Angstrom scale depth scan was surveyed for investigation the zinc speciation. No signal of zinc was detected in the depth of 900A for the larger particle contaminated soils whereas the detectable signal of zinc was determined in the XPS experiment. With further regression and fitting results, the major zinc species presented in the surface of larger and fine particle contaminated soils consisted of reductive and oxidative zinc species. In the deeper depth of contaminated soils, an inverse spinel zinc ferrite was found in the case of larger particle soil. No inverse spinel zinc ferrite was detected in the case of fine particle soil and could be attributed to the relatively small particle size.

Industrial Waste↗

Short-term zinc kinetics in pregnant rats fed marginal zinc diets.

The effect of pregnancy and a chronic, marginal intake of zinc on zinc kinetics was studied in rats. Weanling female rats were fed either a zinc-adequate diet, containing 30 microg Zn/g, (30Zn) (n = 16) or a marginally zinc-deficient diet, containing 6 microg Zn/g, (6Zn) (n = 16). After 6 wk, half of each group was mated (30ZnPG, 6ZnPG). A third group of pregnant rats was pair-fed (PFPG) (n = 6) to the 6ZnPG group. On d 20 of gestation, or at the end of the 9-wk study, 65Zn was injected intravenously. The plasma 65Zn disappearance curve over the next 105 min was used to study the size and fractional turnover rates of two rapidly exchanging zinc metabolic pools (pool a and pool b). Plasma zinc concentrations on d 20 of gestation were significantly lower in the 6ZnPG group compared with the 30ZnPG and PFPG controls, (P < 0.05). The exchangeable pools were also smaller in the 6ZnPG group compared with the 30ZnPg and PFPG groups, (P < 0.02); this reduction was accompanied by a 60% greater fractional turnover rate of pool a, (P < 0.02). Pregnancy outcomes did not differ among the three groups. We conclude that there is an increase in the turnover rate of the exchangeable plasma zinc pool when dietary zinc intake is marginal during pregnancy. This response may help maintain a supply of zinc to the growing fetus when plasma zinc concentrations are reduced.

Animals↗

Demonstrating zinc and iron bioavailability from intrinsically labeled microencapsulated ferrous fumarate and zinc gluconate Sprinkles in young children.

Nutrient-nutrient interactions are an important consideration for any multiple-micronutrient formulation, including Sprinkles, a home-fortification strategy to control anemia. The objectives of this randomized controlled trial were as follows: 1) to compare the absorption of zinc at 2 doses given as Sprinkles; and 2) to examine the effect of zinc and ascorbic acid (AA) on iron absorption from Sprinkles. Seventy-five children aged 12-24 mo were randomly assigned to the following groups: 1) 5 mg of labeled zinc (67Zn) with 50 mg AA (LoZn group); b) 10 mg of labeled zinc (67Zn) with 50 mg AA (HiZn group); or 3) 5 mg zinc with no AA (control). All groups contained 30 mg of labeled iron (57Fe). Intravenous infusions labeled with 70Zn (LoZn and HiZn groups) and 58Fe (control) were administered. Blood was drawn at baseline, 48 h and 14 d later. The percentage of zinc absorbed did not differ between LoZn (geometric mean = 6.4%; min-max: 1.7-14.6) and HiZn (geometric mean = 7.5%; min-max: 3.3-18.0) groups. However, total zinc absorbed was significantly different between the LoZn (geometric mean = 0.31 mg; min-max: 0.08-0.73) and HiZn (geometric mean = 0.82 mg; min-max: 0.33-1.82) groups (P = 0.0004). Geometric mean percentage iron absorption values did not differ between the LoZn (5.9%; min-max: 0.8-21) and HiZn (4.4%; min-max: 0.6-12.3) groups and between the LoZn and control groups (5.0%; min-max: 1.4-24). We conclude that zinc in the form of Sprinkles has a low bioavailability, yet provides adequate amounts of absorbed zinc in young children, and that there is no effect of zinc or AA on iron absorption from the given formulations of Sprinkles.

Absorption↗

65Zn-labeled tissue zinc for determination of endogenous fecal zinc excretion in growing rats.

Experiments were conducted to study whether selected body tissues other than blood plasma provide suitable endogenous zinc sources to determine endogenous fecal zinc excretion and zinc absorbability by the radioisotope dilution technique. In 16 rats with a mean weight of 172 g on the day of 65Zn injection, the apparent digestibility of zinc (12.8 mg Zn/kg diet dry matter) averaged 72.4 +/- 6.2% during a 6-day balance period starting 9 days postinjection. Based on the specific radioactivity of zinc in plasma after 10 days, two-thirds of the fecal zinc were of endogenous origin and the corresponding zinc absorbability averaged about 91%. Zinc absorbabilities computed on the basis of the specific radioactivity of zinc in the small intestine, pancreas and/or kidneys after 15 days were closely comparable to the mean derived with plasma. Other tissues examined were found less suitable to reflect the specific radioactivity of endogenous fecal zinc.

Animals↗

Urinary zinc excretion and zinc status of patients with beta-thalassemia major.

In this study, zinc status and urinary zinc excretion with and without desferrioxamine (DFO) infusion and the relationship between urinary zinc excretion and renal tubular dysfunction in thalassemia major (TM) patients were investigated. Forty TM patients were given four DFO infusions on alternate days over a 1-wk period prior to the transfusion. On each day that DFO was given, a 24-h urine collection initiated. DFO was omitted for 1-wk before the following transfusion and during the period four 24-h urine collections were performed. Twenty healthy children provided 24-h urine collection as controls. Blood samples were taken on each of two consecutive transfusion days of the patients and from the controls. Urinary zinc excretion was measured and plasma and red blood cell (RBC) zinc analysis were performed by inductively coupled plasma-atomic emission spectrophotometry. Urinary N-acetyl-beta-D-glucosaminidase (NAG) activity and creatinine were determined in morning urine specimens. The mean plasma zinc concentration was significantly lower in the patients not given DFO compared to the values of the patients given DFO and the control group. The mean RBC zinc concentration (micromol/g Hb) in the patients (with and without DFO) and the control group were similar. Urinary zinc excretion was significantly higher in the patients receiving DFO compared to the control group, whereas urinary zinc excretion in the patients not given DFO was not different from the controls. Urinary NAG indices (U/g Cr) were significantly higher in the patients compared to controls. Urinary zinc excretion was correlated with the urinary NAG indices.

Adolescent↗

Human oral retention of zinc from mouthwashes containing zinc salts and its relevance to dental plaque control.

Subjects using 30 mM zinc phenolsulphonate as a mouthwash retained 12 per cent of the zinc. Salivary zinc concentration was increased by using mouthwashes containing 17-35 mM zinc as the sulphate, phenolsulphonate or citrate. For 17 mM zinc sulphate or phenolsulphonate, the effect lasted 3-4 h. Zinc retained in the mouth gave visible fluorescence after rinsing with 8-hydroxyquinoline and was particularly evident on the tongue, cheek mucosa and dental plaque. The concentration of zinc in plaque was increased 13-19-fold 1 h after using 31 or 18 mM zinc phenolsulphonate. A 3-fold increase was still present 6 h later for the 31 mM mouthwash. Zinc salts inhibited acid production from [14C]-glucose in vitro by plaque at concentrations which were found in plaque in vivo after using the mouthwashes. The effect of zinc on the metabolic activity of plaque may reduce the growth rate of plaque-bacteria and so decrease plaque growth.

Acids↗

Effect of dipicolinate, a chelator of zinc, on bone protein synthesis in tissue culture. The essential role of zinc.

The present investigation was undertaken to clarify the essential role of zinc on bone protein synthesis in tissue culture. Calvariae were removed from 3-week-old male rats and cultured for periods up to 72 hr in Dulbecco's Modified Eagle Medium (high glucose, 4500 mg/dl) supplemented with antibiotics and bovine serum albumin. The calvariae were incubated for 24 hr at 37 degrees in 5% CO2/95% air in medium containing 10(-6)-10(-3) M dipicolinate, a chelator of zinc, and then the bones were transferred into medium containing either 10(-4) M zinc sulfate or vehicle without dipicolinate. Zinc content in bone tissues was decreased when the culture was treated with 10(-4) and 10(-3) M dipicolinate for 24 hr. When calvariae treated with 10(-4) M dipicolinate for 24 hr were further cultured in medium without dipicolinate for 24 and 48 hr, bone alkaline phosphatase activity was decreased by about 40% (P less than 0.01) of untreated bone enzyme activity. The decreased alkaline phosphatase activity was increased markedly by the presence of 10(-4) M zinc (about 2.5-fold of control value). This effect of zinc was blocked completely by the presence of 10(-7) M cycloheximide, but 10(-8) M actinomycin D caused only a partial inhibition. When calvariae treated with 10(-4) M dipicolinate were pulsed with [3H]proline, the incorporation of [3H]proline into the acid-insoluble residues of bone tissue was decreased by about 40% (P less than 0.01) of the value obtained from calvariae not treated with dipicolinate. The presence of 10(-4) M zinc caused an increase of about 2-fold in [3H]proline incorporation. Bone DNA content was not altered significantly by treatment with 10(-4) dipicolinate or 10(-4) M zinc. These results clearly indicate that endogenous zinc induces the stimulation of protein synthesis at the translational process in bone cells. The present study further supports the view that zinc plays an essential role for protein synthesis in bone cells.

Alkaline Phosphatase↗

Myotonic dystrophy: a disease caused by functional zinc deficiency due to an abnormal zinc-binding ligand?

There are large amounts of zinc in muscle and zinc ions can enhance the degree of muscle contraction in response to direct stimulation while at the same time inhibiting neuromuscular transmission. The opposites of these effects would lead to myotonia and muscle weakness. There are many parallels between the non-muscular features of myotonic dystrophy and those of zinc deficiency. The particular patterns of reproductive disturbance in both males and females, the abnormalities of metabolism, the defects in gut funcion, the defects in bone and the congenital abnormalities are very similar in the two conditions. However there are important differences between simply zinc deficiency states and myotonic dystrophy which mean that the latter is unlikely to be due to the former. Instead it is proposed that the fundamental defect in myotonic dystrophy is the presence of an abnormal zinc binding ligand which fails to deliver appropriate amounts of zinc ions to the tissues. The functioning of this ligand may, however, be affected by dietary zinc, perhaps accounting for the apparent variation in the expression of the dominant myotonic dystrophy gene due to some unknown environmental factor. Some of the effects of zinc may be due to lack of the zinc ion directly, while others are probably related to defects in essential fatty acid and prostaglandin metabolism. The hypothesis can be readily tested by the employment of nutritional measures designed to counteract the defects in zinc and essential fatty acid metabolism.

Bone Diseases↗

Fluorescence-based zinc ion sensor for zinc ion release from pancreatic cells.

In this paper, we describe the synthesis and characterization of analytical properties of fluorescence-based zinc ion-sensing glass slides and their application in monitoring zinc ion release from beta pancreatic cells in cell cultures. To fabricate the sensors, the zinc ion indicator ZnAF-2 {6-[N-[N',N'-bis(2-pyridinylmethyl)-2-aminoethyl]amino-3',6'-dihydroxyspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one} was modified to include a sufficiently long linking aliphatic chain with a terminal carboxyl functional group. The recently synthesized ZnAF-2 zinc ion indicator provided high zinc ion selectivity in physiological solutions containing millimolar levels of calcium and other possible interfering cations. The carboxyl-modified ZnAF-2 was conjugated to the activated surface of glass slides, which then served as zinc ion sensors. It was possible to grow pancreatic cells directly on the zinc-sensing glass slide or on a membrane placed on these glass slides. The sensors were used to monitor zinc ion release events from glucose-stimulated pancreatic cells. The study showed that the zinc ion sensors responded effectively to the release of zinc ions from pancreatic cells at the nanomolar level with high selectivity and rapid subsecond response time.

Animals↗

Interaction of zinc and hemoglobin: binding of zinc and the oxygen affinity.

Stripped human hemoglobin was shown to have a high apparent zinc association constant of 1.3 X 10(7) M-1 with a stoichiometry of one zinc for every two hemes. The saturation of this site produces a dramatic 3.7-fold increase in the oxygen affinity. The effect of zinc on the oxygen affinity is interrelated with the interaction of 2,3-diphosphoglyceric acid (2,3-DPG) and hemoglobin. Thus, a smaller zinc effect is observed in the presence of added 2,3-DPG. Information about the location of the zinc-binding site responsible for the increased oxygen affinity has been obtained by comparing the binding of zinc to various hemoglobins. Blocking the beta93 sulfhydryl group decreases the apparent zinc association constant by an order of magnitude. The substitution of histidine-beta143 in hemoglobin Abruzzo [beta143 (H21) His leads to Arg] and hemoglobin Little Rock [beta143 (H21) His leads to Gln] decreases the apparent zinc association constant by two orders of magnitude. The substitution of histidine-beta143 by other amino acids and the reaction of the beta93 sulfhydryl group are known to produce dramatic increases in the oxygen affinity. The binding of zinc to one or both of these amino acids can, therefore, explain the zinc-induced increase in the oxygen affinity.

Diphosphoglyceric Acids↗

The acrodermatitis enteropathica gene ZIP4 encodes a tissue-specific, zinc-regulated zinc transporter in mice.

The human ZIP4 gene (SLC39A4) is a candidate for the genetic disorder of zinc metabolism acrodermatitis enteropathica. To understand its role in zinc homeostasis, we examined the function and expression of mouse ZIP4. This gene encodes a well conserved eight-transmembrane protein that can specifically increase the influx of zinc into transfected cells. Expression of this gene is robust in tissues involved in nutrient uptake, such as the intestines and embryonic visceral yolk sac, and is dynamically regulated by zinc. Dietary zinc deficiency causes a marked increase in the accumulation of ZIP4 mRNA in these tissues, whereas injection of zinc or increasing zinc content of the diet rapidly reduces its abundance. Zinc can also regulate the accumulation of ZIP4 protein at the apical surface of enterocytes and visceral endoderm cells. These results provide compelling evidence that ZIP4 is a zinc transporter that plays an important role in zinc homeostasis, a process that is defective in acrodermatitis enteropathica in humans.

Acrodermatitis↗